Related Experiment Video
Updated: Jul 9, 2026
Antibody-Free Assay for RNA Methyltransferase Activity Analysis
Published on: July 9, 2019
The emerging role of NAT10-mediated N4-acetylcytidine modification of RNA in bone diseases: Current frontiers and
Gan Luo1, Zhihan Ning2, Hong Yang2
1Department of Orthopedics, Chengdu Integrated Traditional Chinese Medicine & Western Medicine Hospital/Chengdu First People's Hospital, Chengdu, China; School of Medical & Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Aims:
To review the biosynthesis, regulatory mechanisms, and functional roles of N-acetyltransferase 10 (NAT10)-mediated N4-acetylcytidine (ac4C) RNA modification in bone and joint diseases, and to evaluate its therapeutic potential.
Materials And Methods:
A systematic literature search was conducted using PubMed, Web of Science, and Scopus databases for articles published up to May 2026 addressing NAT10, ac4C RNA modification, and bone diseases including osteoporosis, inflammatory bone loss, osteoarthritis, osteosarcoma, and bone marrow mesenchymal stem cell (BMSC) differentiation. Studies investigating ac4C modification mechanisms, detection methods, and therapeutic interventions were critically reviewed and synthesized.
Key Findings:
NAT10, the primary known ac4C writer, catalyzes ac4C on rRNA, tRNA, and potentially mRNA, thereby regulating RNA stability and translation efficiency. Accumulating evidence indicates that NAT10-mediated ac4C influences skeletal homeostasis through several distinct routes. It promotes osteogenic differentiation of BMSCs by stabilizing RUNX2 mRNA, drives osteoclastogenesis through Fos/NFATc1 signaling, and modulates inflammation in periodontitis and rheumatoid arthritis. It further promotes osteoarthritis by suppressing chondrogenic programs and fuels osteosarcoma through metabolic reprogramming. Pharmacological NAT10 inhibition with Remodelin shows therapeutic potential in preclinical models, although its specificity remains incompletely characterized.
Significance:
NAT10-mediated ac4C modification represents an emerging regulatory mechanism in skeletal biology. Accumulating evidence supports its involvement in osteoporosis, inflammatory bone loss, osteoarthritis, and osteosarcoma through effects on RNA stability, translation efficiency, and downstream signaling. Substantial gaps nonetheless remain. In particular, it is still unclear how ac4C on specific transcripts controls bone- and cartilage-cell function, and to what extent these modifications are dynamically regulated across disease states.
Related Concept Videos
02:23RNA Editing
01:20Types of RNA
RNA Performs Diverse...
01:23Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
02:55The Nucleolus
01:28Biosynthesis of Nucleic Acids
01:31Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life